Figure 2 from Determinants and Effectiveness of Extending the Duration of Adjuvant Hormone Therapy beyond 5 Years in Patients with Breast Cancer
<p>Use of adjuvant hormone therapy across 10 years in women diagnosed with breast cancer in Stockholm, Sweden, 2005–2020. The dashed vertical lines indicate six months after finishing 5 years of adjuvant hormone therapy—a period that was used to define therapy extension.</p>
Saved in:
| 主要作者: | |
|---|---|
| 其他作者: | , , , |
| 出版: |
2025
|
| 主題: | |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|